By Melissa Lipman ( November 17, 2014, 4:19 PM EST) -- The Third Circuit on Wednesday will become the first court of appeals to take on a pay-for-delay case since the U.S. Supreme Court ruled the pharmaceutical patent settlements could face antitrust scrutiny, weighing the key question of whether generic-drug makers must receive cash for a deal to count as a reverse payment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.